Dogwood Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.3K Buy
72
+22
+44% +$3.3K ﹤0.01% 357
2026
Q1
$7.64K Buy
50
+28
+127% +$4.29K ﹤0.01% 391
2025
Q4
$3.03K Buy
+22
New +$2.88K ﹤0.01% 499

Other funds holding NVS

Dogwood Wealth Management's NVS Position: Q2 2026 in Review

Dogwood Wealth Management increased its Novartis (NVS) stake by 44% in Q2 2026, buying an estimated $3.3K and bringing the position to 72 shares worth $11.3K. The position accounts for ﹤0.01% of the portfolio, ranked #357.

Dogwood Wealth Management first reported a position in NVS in Q4 2025 and has held it in 3 quarters since. 1,625 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Dogwood Wealth Management held 72 shares of Novartis worth $11.3K as of Q2 2026.
  • Dogwood Wealth Management bought 22 Novartis shares in Q2 2026, an estimated $3.3K.
  • Novartis made up ﹤0.01% of Dogwood Wealth Management's portfolio in Q2 2026, its #357 holding.
  • Dogwood Wealth Management first reported a position in Novartis in Q4 2025 and has held it in 3 quarters since.
  • 1,625 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Dogwood Wealth Management's 13F filing for Q2 2026, filed 6 Jul 2026.